Skip to main content

From the Helm: CSL’s David Lamont on the biotech giant’s bright future

Jessica Amir
February 20, 2020

In the latest instalment of Bell Direct’s From the Helm series, Jess has a chat with CSL’s CFO David Lamont.

David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL’s own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.

Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL’s future proofing strategy.

Weekly Wrap 28 August

Bell Direct
August 28, 2020

Morning Bell 28 August

Jessica Amir
August 28, 2020

Morning Bell 27 August

Jessica Amir
August 27, 2020

Morning Bell 26 August

Bell Direct
August 26, 2020

Morning Bell 25 August

Jessica Amir
August 25, 2020

Morning Bell 24 August

Jessica Amir
August 24, 2020

Weekly Wrap 21 August

Jessica Amir
August 21, 2020

Morning Bell 21 August

Jessica Amir
August 21, 2020